Analysts think CRIS stock price could increase by 406%
Nov 24, 2024, 12:26 PM
-19.35%
What does CRIS do
Curis, headquartered in Lexington, Massachusetts, focuses on developing cancer treatments, including emavusertib for various lymphomas and leukemias, alongside other candidates like Fimepinostat and CA-170. The company, which went public in 2000, employs 48 full-time staff.
6 analysts think CRIS stock price will increase by 406.20%. The current median analyst target is $20.40 compared to a current stock price of $4.03. The lowest analysts target is $18.18 and the highest analyst target is $27.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.